# FDA 483 - BASF Corporation - May 29, 2025

Source: https://www.globalkeysolutions.net/records/483/basf-corporation/708193f8-55a9-4882-9db1-fa4d45b2e33e

> FDA 483 for BASF Corporation on May 29, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BASF Corporation
- Inspection Date: 2025-05-29
- Product Type: drugs
- Office Name: New York District Office
- Summary: An FDA inspection of BASF Corporation in East Setauket, NY, from May 27-29, 2025, revealed a significant deficiency in the firm's quality control. The company failed to establish and follow procedures for qualifying raw material suppliers and did not perform full confirmatory testing of incoming raw materials against certificates of analysis, potentially compromising the quality of their drug products.

## Related Documents

- [483 - 2017-11-17](https://www.globalkeysolutions.net/records/483/basf-corporation/bc2c0d1e-80b8-4f1c-b18d-7fce15c869a0)

## Related Officers

- [Amatul H. Marium](https://www.globalkeysolutions.net/people/amatul-h-marium/5db400ce-ffde-4310-82f8-766fd2458a4d)

Company: https://www.globalkeysolutions.net/companies/basf-corporation/c1e582b1-32db-4730-a43c-5023d59a5654

Office: https://www.globalkeysolutions.net/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d